192
Views
9
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Low-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor for elderly patients with de novo acute myeloid leukemia

, &
Pages 141-146 | Received 24 Nov 2013, Accepted 30 Mar 2014, Published online: 16 Jun 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fang Wang, Wenyan Xu, Li Liu, Xiuhong Ren, Pingping Liu, Li Zheng, Hao Zhang, Songsong Zhang, Yaru Xu & Zhenxing Guo. (2021) Low dose of homoharringtonine and cytarabine-based priming induction regimens for patients with de novo acute myeloid leukemia and high-risk myelodysplastic syndrome aged over 70 years. Hematology 26:1, pages 1040-1045.
Read now

Articles from other publishers (8)

Jiayi Cai, Honghui Huang, Xiaoli Hu, Wenjing Lang, Wanbin Fu, Lan Xu, Zilong Qiu, Hua Zhong & Fangyuan Chen. (2021) Homoharringtonine Synergized with Gilteritinib Results in the Downregulation of Myeloid Cell Leukemia-1 by Upregulating UBE2L6 in FLT3-ITD-Mutant Acute Myeloid (Leukemia) Cell Lines. Journal of Oncology 2021, pages 1-11.
Crossref
Abinaya Muralidharan, J. Julius Xavier Scott, Leena Dennis Joseph & Srikanth Jeyabalan. (2022) Effect of Homoharringtonine as a Combined Regimen for Acute Myeloid Leukemia. Journal of Pharmacology and Pharmacotherapeutics 12:3, pages 110-114.
Crossref
Ping Chen, Weiwu Zhan, Bin Wang, Peidong You, Qing Jin, Diyu Hou, Xiaoting Wang, Ruolan You, Hong Zou, Yuanzhong Chen & Huifang Huang. (2019) Homoharringtonine potentiates the antileukemic activity of arsenic trioxide against acute myeloid leukemia cells. Experimental Cell Research 376:2, pages 114-123.
Crossref
Jingsong He, Li Li, Jingjing Zhu, Weiyan Zheng, Wenjun Wu, Yanlong Zheng & Xiujin Ye. (2017) Novel homobarringtonie‑containing therapy for the treatment of patients with primary acute myeloid leukemia that are resistant to conventional therapy. Oncology Letters.
Crossref
Ping Chen, Qin Yuan, Hui Yang, Xiaofang Wen, Peidong You, Diyu Hou, Jieqiong Xie, Yu Cheng & Huifang Huang. (2017) Homoharringtonine enhances bortezomib antimyeloma activity in myeloma cells adhesion to bone marrow stromal cells and in SCID mouse xenografts. Leukemia Research 57, pages 119-126.
Crossref
Joëlle Pérard-Viret, Laith Quteishat, Rana Alsalim, Jacques Royer & Françoise Dumas. 2017. 205 352 .
Mixue Xie, Qi Jiang, Li Li, Jingjing Zhu, Lixia Zhu, De Zhou, Yanlong Zheng, Xiudi Yang, Mingyu Zhu, Jianai Sun, Wanzhuo Xie & Xiujin Ye. (2016) HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants. PLOS ONE 11:10, pages e0164238.
Crossref
Sijing Wu, Shijia Yang, Li Zhu, Ying Wang, Yicheng Zhang, Jianfeng Zhou & Dengju Li. (2016) Prognosis of Patients With de novo Acute Myeloid Leukemia Resistant to Initial Induction Chemotherapy. The American Journal of the Medical Sciences 351:5, pages 473-479.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.